Praxis Precision Medicines Files 8-K
Ticker: PRAX · Form: 8-K · Filed: Dec 29, 2025 · CIK: 1689548
| Field | Detail |
|---|---|
| Company | Praxis Precision Medicines, Inc. (PRAX) |
| Form Type | 8-K |
| Filed Date | Dec 29, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory-filing
TL;DR
Praxis Precision Medicines filed an 8-K on 12/29/25 for 'Other Events' - details TBD.
AI Summary
Praxis Precision Medicines, Inc. filed an 8-K on December 29, 2025, to report "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself. The company is incorporated in Delaware and headquartered in Boston, Massachusetts.
Why It Matters
This 8-K filing indicates that Praxis Precision Medicines has reported an event requiring immediate disclosure to the SEC, which could be material to investors.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events' without immediate disclosed specifics, creating uncertainty about the nature and impact of the reported event.
Key Players & Entities
- Praxis Precision Medicines, Inc. (company) — Registrant
- December 29, 2025 (date) — Date of earliest event reported
- Boston, Massachusetts (location) — Principal executive offices location
- 02110 (postal_code) — Zip code for principal executive offices
- 617-300-8460 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by Praxis Precision Medicines, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported beyond the general classification.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on December 29, 2025.
Where are the principal executive offices of Praxis Precision Medicines, Inc. located?
The principal executive offices of Praxis Precision Medicines, Inc. are located at 99 High Street, 30th Floor, Boston, Massachusetts 02110.
What is the telephone number for Praxis Precision Medicines, Inc.?
The telephone number for Praxis Precision Medicines, Inc. is (617) 300-8460.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 462 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-12-29 08:04:41
Key Financial Figures
- $0.0001 — ge on which registered Common Stock, $0.0001 par value per share PRAX The Nasdaq Glo
Filing Documents
- prax-20251229.htm (8-K) — 28KB
- 0001689548-25-000118.txt ( ) — 142KB
- prax-20251229.xsd (EX-101.SCH) — 2KB
- prax-20251229_lab.xml (EX-101.LAB) — 22KB
- prax-20251229_pre.xml (EX-101.PRE) — 13KB
- prax-20251229_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On December 29, 2025, Praxis Precision Medicines, Inc. (the "Company") announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation ("BTD") for ulixacaltamide for the treatment of patients with essential tremor ("ET"). The BTD enables expedited development and regulatory review for drugs that are intended to treat a serious condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies. The BTD for ulixacaltamide was based on the positive topline data from the Essential3 program, consisting of two pivotal Phase 3 studies of ulixacaltamide in ET. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRAXIS PRECISION MEDICINES, INC. Date: December 29, 2025 By: /s/ Marcio Souza Marcio Souza Chief Executive Officer